Analysis of the topic study using 2010 mcdonald criteria
Conclusions
Teriflunomide demonstrates a consistent treatment effect in patients with MS diagnosed according to differing diagnostic criteria. (Study supported by Genzyme, a Sanofi company).
Source: Journal of Neurology, Neurosurgery and Psychiatry - Category: Neurosurgery Authors: Rog, D., Wolinsky, J., Truffinet, P., Thangavelu, K., Miller, A. Tags: Immunology (including allergy), Multiple sclerosis, Radiology, Radiology (diagnostics) Thur 21, Parallel session 5: Therapeutics Source Type: research
More News: Allergy | Allergy & Immunology | Brain | MRI Scan | Multiple Sclerosis | Neurology | Neurosurgery | Psychiatry | Radiology | Study